Analysts' Actions: BA, EW, ZNGA, JCP, BBY

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Adobe Systems ( ADBE) downgraded at Jefferies to Hold from Buy, Jefferies said. $32 price target. Too much change to navigate comfortably.

Best Buy ( BBY) upgraded at Citigroup to Neutral from Sell, Citigroup said. $21 price target. More balanced risk/reward after 35% pullback.

Beneficial Mutual Bancorp ( BNCL) downgraded to hold at TheStreet Ratings.

Clean Energy Fuels ( CLNE) downgraded to sell at TheStreet Ratings.

Human Genome ( HGSI) downgraded at JMP from Outperform to Market Perform, JMP Securities said. Benlysta likely faces an uphill battle to gain adoption for doctors treating lupus.

Immunogen ( IMGN) rated new Hold at Cantor. $15 price target. Stock is already factoring in commercial revenue expected from Roche deal.

Nike ( NKE) upgraded at McAdams from Sell to Hold, McAdams Wright Ragen said. Stock has pulled back to a fair value.

STOCK COMMENTS / EPS CHANGES

Boeing ( BA) estimates lowered at UBS through 2013, UBS said. Gauging MAX impact on BCA margins. Neutral rating and $72 price target.

Crane ( CR) estimates, target reduced at Keybanc. CR estimates were cut through 2013, Keybanc said. Strong dollar and lower commecial demand could hurt near-term results. Buy rating and new $50 price target.

Ctrip.com International ( CTRP) estimates lowered at Oppenheimer through 2013, Oppenheimer said. Impact of the PRC withholding tax. Outperform rating.

Discover Financial Services ( DFS) numbers raised at Citigroup. Shares of DFS now seen reaching $35, Citigroup said. Estimates also increased to reflect better card credit. Neutral rating.

Equifax ( EFX) estimates, target raised at Credit Suisse. Shares of EFX now seen reaching $50, according to Credit Suisse. Estimates also increased, as the company can likely sustain solid organic sales growth, despite difficult macro conditions. Neutral rating.

Edward Lifesciences ( EW) target raised at Jefferies. Shares of EW now seen reaching $100, Jefferies said. Positive panel paves way for Sapien Label expansion. Buy rating.

Edwards Lifesciences target boosted at BMO. Shares of EW now seen reaching $94, according to BMO Capital. FDA panel was strongly in favor of approving Cohort A. Market Perform rating.

Jabil Circuit ( JBL) numbers cut at Citigroup. Shares of JBL now seen reaching $21, Citigroup said. Estimates also lowered given disappointing outlooks from major customers. Neutral rating.

JC Penney ( JCP) target cut at Morgan Stanley to $22, according to Morgan Stanley. Survey suggests a weaker consumer pricing environment. Underweight rating.

If you liked this article you might like

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Boeing Surge Means it's Time to Lock in More Gains

Boeing Is a 'Buyer' Looking for Acquisitions After Northrop-Orbital Deal